Lung Cancer in Spain-Reference-Cited by-同舟云学术

Lung Cancer in Spain

Published:2021-02 Issue:2 Volume:16 Page:197-204
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Remon Jordi,Reguart Noemí,García-Campelo Rosario,Conde Esther,Lucena Carmen-María,Persiva Oscar,Navarro-Martin Arturo,Rami-Porta Ramón

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference13 articles.

1. Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation;Barquín;Cancer Epidemiol,2020

2. Tendencias en el consumo de tabaco adolescente en España (2002-2018) [Trends in tobacco use among adolescents in Spain (2002-2018)];Leal-López;Adicciones,2019

3. Attributable mortality to radon exposure in Galicia, Spain. Is it necessary to act in the face of this health problem?;Pérez-Ríos;BMC Public Health,2010

4. Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study);Provencio;Transl Lung Cancer Res,2019

5. Recomendaciones SEPAR de diagnóstico y tratamiento del cáncer de pulmón de células no pequeñas [Recommendations of the Spanish Society of Pneumology and Thoracic Surgery on the diagnosis and treatment of non-small-cell lung cancer];Álvarez;Arch Bronconeumol,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in lung cancer incidence in Spain (1990–2019): insights from Global Burden of Diseases data;Clinical and Translational Oncology;2024-06-19

2. Healthcare Resource Utilization and Associated Costs among Patients with Advanced Non-Small-Cell Lung Cancer Receiving Chemotherapy or Immunotherapy in Spain: A Single-Center, Real-World, Exploratory Study;Cancers;2024-05-30

3. Time Dependence Between Tobacco Consumption and Lung Cancer Mortality in Spain;Archivos de Bronconeumología;2024-05

4. Radon, Concrete, Buildings and Human Health—A Review Study;Buildings;2024-02-13

5. Economic evaluation of adjuvant therapy with osimertinib in patients with early-stage non–small cell lung cancer and mutated EGFR;Supportive Care in Cancer;2023-12-27